These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 31980132)
1. Moderators of treatment efficacy in individualized metacognitive training for psychosis (MCT+). Leanza L; Studerus E; Bozikas VP; Moritz S; Andreou C J Behav Ther Exp Psychiatry; 2020 Sep; 68():101547. PubMed ID: 31980132 [TBL] [Abstract][Full Text] [Related]
2. Investigating the efficacy of an individualized metacognitive therapy program (MCT+) for psychosis: study protocol of a multi-center randomized controlled trial. Schneider BC; Brüne M; Bohn F; Veckenstedt R; Kolbeck K; Krieger E; Becker A; Drommelschmidt KA; Englisch S; Eisenacher S; Lee-Grimm SI; Nagel M; Zink M; Moritz S BMC Psychiatry; 2016 Feb; 16():51. PubMed ID: 26921116 [TBL] [Abstract][Full Text] [Related]
3. Individualized metacognitive therapy for delusions: A randomized controlled rater-blind study. Andreou C; Wittekind CE; Fieker M; Heitz U; Veckenstedt R; Bohn F; Moritz S J Behav Ther Exp Psychiatry; 2017 Sep; 56():144-151. PubMed ID: 27919404 [TBL] [Abstract][Full Text] [Related]
4. Individualized Metacognitive Training (MCT+) Reduces Delusional Symptoms in Psychosis: A Randomized Clinical Trial. Balzan RP; Mattiske JK; Delfabbro P; Liu D; Galletly C Schizophr Bull; 2019 Jan; 45(1):27-36. PubMed ID: 30376124 [TBL] [Abstract][Full Text] [Related]
5. Metacognitive group training for schizophrenia spectrum patients with delusions: a randomized controlled trial. van Oosterhout B; Krabbendam L; de Boer K; Ferwerda J; van der Helm M; Stant AD; van der Gaag M Psychol Med; 2014 Oct; 44(14):3025-35. PubMed ID: 25066223 [TBL] [Abstract][Full Text] [Related]
7. The Efficacy of Metacognitive Training for Delusions in Patients With Schizophrenia: A Meta-Analysis of Randomized Controlled Trials Informs Evidence-Based Practice. Liu YC; Tang CC; Hung TT; Tsai PC; Lin MF Worldviews Evid Based Nurs; 2018 Apr; 15(2):130-139. PubMed ID: 29489070 [TBL] [Abstract][Full Text] [Related]
8. Randomized control trial to assess the efficacy of metacognitive training compared with a psycho-educational group in people with a recent-onset psychosis. Ochoa S; López-Carrilero R; Barrigón ML; Pousa E; Barajas A; Lorente-Rovira E; González-Higueras F; Grasa E; Ruiz-Delgado I; Cid J; Birulés I; Esteban-Pinos I; Casañas R; Luengo A; Torres-Hernández P; Corripio I; Montes-Gámez M; Beltran M; De Apraiz A; Domínguez-Sánchez L; Sánchez E; Llacer B; Pélaez T; Bogas JL; Moritz S; Psychol Med; 2017 Jul; 47(9):1573-1584. PubMed ID: 28166848 [TBL] [Abstract][Full Text] [Related]
9. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial. Moritz S; Veckenstedt R; Andreou C; Bohn F; Hottenrott B; Leighton L; Köther U; Woodward TS; Treszl A; Menon M; Schneider BC; Pfueller U; Roesch-Ely D JAMA Psychiatry; 2014 Oct; 71(10):1103-11. PubMed ID: 25103718 [TBL] [Abstract][Full Text] [Related]
10. Decreasing self-reported cognitive biases and increasing clinical insight through meta-cognitive training in patients with chronic schizophrenia. Gawęda Ł; Krężołek M; Olbryś J; Turska A; Kokoszka A J Behav Ther Exp Psychiatry; 2015 Sep; 48():98-104. PubMed ID: 25775947 [TBL] [Abstract][Full Text] [Related]
12. Sustained antipsychotic effect of metacognitive training in psychosis: a randomized-controlled study. Favrod J; Rexhaj S; Bardy S; Ferrari P; Hayoz C; Moritz S; Conus P; Bonsack C Eur Psychiatry; 2014 Jun; 29(5):275-81. PubMed ID: 24176646 [TBL] [Abstract][Full Text] [Related]
13. Embracing Psychosis: A Cognitive Insight Intervention Improves Personal Narratives and Meaning-Making in Patients With Schizophrenia. Moritz S; Mahlke CI; Westermann S; Ruppelt F; Lysaker PH; Bock T; Andreou C Schizophr Bull; 2018 Feb; 44(2):307-316. PubMed ID: 29106693 [TBL] [Abstract][Full Text] [Related]
14. Gender differences in response to metacognitive training in people with first-episode psychosis. Salas-Sender M; López-Carrilero R; Barajas A; Lorente-Rovira E; Pousa E; Barrigón ML; Grasa E; Ruiz-Delgado I; González-Higueras F; Cid J; Aznar A; Pélaez T; Birulés I; Moritz S; The Spanish Metacognition Study Group ; Ochoa S J Consult Clin Psychol; 2020 Jun; 88(6):516-525. PubMed ID: 31855037 [TBL] [Abstract][Full Text] [Related]
15. The influence of metacognitive training on delusion severity and metacognitive ability in schizophrenia. Erawati E; Keliat BA; Helena N; Hamid A J Psychiatr Ment Health Nurs; 2014; 21(9):841-7. PubMed ID: 24548341 [TBL] [Abstract][Full Text] [Related]
16. The Effect of Reducing the "Jumping to Conclusions" Bias on Treatment Decision-Making Capacity in Psychosis: A Randomized Controlled Trial With Mediation Analysis. Turner DT; MacBeth A; Larkin A; Moritz S; Livingstone K; Campbell A; Hutton P Schizophr Bull; 2019 Jun; 45(4):784-793. PubMed ID: 30260458 [TBL] [Abstract][Full Text] [Related]
17. Complementary group Metacognitive Training (MCT) reduces delusional ideation in schizophrenia. Moritz S; Veckenstedt R; Bohn F; Hottenrott B; Scheu F; Randjbar S; Aghotor J; Köther U; Woodward TS; Treszl A; Andreou C; Pfueller U; Roesch-Ely D Schizophr Res; 2013 Dec; 151(1-3):61-9. PubMed ID: 24183707 [TBL] [Abstract][Full Text] [Related]
18. Metacognitive training for young subjects (MCT young version) in the early stages of psychosis: Is the duration of untreated psychosis a limiting factor? Ussorio D; Giusti L; Wittekind CE; Bianchini V; Malavolta M; Pollice R; Casacchia M; Roncone R Psychol Psychother; 2016 Mar; 89(1):50-65. PubMed ID: 25799999 [TBL] [Abstract][Full Text] [Related]
19. The London-East Anglia randomized controlled trial of cognitive-behaviour therapy for psychosis. IV: Self-esteem and persecutory delusions. Freeman D; Garety P; Fowler D; Kuipers E; Dunn G; Bebbington P; Hadley C Br J Clin Psychol; 1998 Nov; 37(4):415-30. PubMed ID: 9856295 [TBL] [Abstract][Full Text] [Related]
20. Metacognitive training in patients recovering from a first psychosis: an experience sampling study testing treatment effects. Pos K; Meijer CJ; Verkerk O; Ackema O; Krabbendam L; de Haan L Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):57-64. PubMed ID: 28828697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]